1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1. (23rd October 2018) - Hansen, A; Bauer, T M; Moreno, V; Maio, M; Groenland, S; Martin-Liberal, J; Gan, H; Rischin, D; Millward, M; Olszanski, A J; Cho, D C; Paul, E; et al.